NCT00161928View on ClinicalTrials.gov

Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants

PHASE3CompletedINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

April 30, 2002

Study Completion Date

January 31, 2003

Conditions
Meningitis, Meningococcal
Interventions
BIOLOGICAL

Group C Meningococcal Polysaccharide-Tetanus Toxoid Conjugate Vaccine (GCMP-TT)

Trial Locations (14)

4040

Freistädter Strasse 290, Linz

4600

Grieskirchner Strasse 17, Wels

10967

Hasenheide 66, Berlin

74072

Solothurner Strasse 2, Heilbronn

74321

Hauptstrasse 9, Bietigheim-Bissingen

77656

Asternweg 11a, Offenburg

77694

Haupstrasse 240, Kehl

77955

Rheinstrasse13, Ettenheim

78727

Tuchbergstrasse 2, Oberndorf / Neckar

86163

Neuschwansteinstrasse 5, Augsburg

86720

Löpsinger Strasse 8, Nördlingen

88250

Broner Platz 6, Weingarten

88348

Marktplatz 3, Bad Saulgau

93426

Falkensteiner Strasse 24, Roding

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY